160 related articles for article (PubMed ID: 30663177)
1. Low dose isotretinoin as an adjuvant therapy for treatment of different clinical variants of warts: A case series.
Dave DD; Abdelmaksoud A
Dermatol Ther; 2019 Mar; 32(2):e12836. PubMed ID: 30663177
[TBL] [Abstract][Full Text] [Related]
2. Extensive and recalcitrant common warts in an immunocompetent patient: rapid and complete remission after oral isotretinoin monotherapy.
Pasmatzi E; Badavanis G; Kapranos N; Apostolidou A; Monastirli A; Tsambaos D
Acta Dermatovenerol Alp Pannonica Adriat; 2020 Mar; 29(1):35-37. PubMed ID: 32206821
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, randomized, placebo-controlled trial of oral isotretinoin in the treatment of recalcitrant facial flat warts.
Olguin-García MG; Jurado-Santa Cruz F; Peralta-Pedrero ML; Morales-Sánchez MA
J Dermatolog Treat; 2015 Feb; 26(1):78-82. PubMed ID: 24547881
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the efficacy and safety of oral isotretinoin versus topical isotretinoin in the treatment of plane warts: a randomized open trial.
Kaur GJ; Brar BK; Kumar S; Brar SK; Singh B
Int J Dermatol; 2017 Dec; 56(12):1352-1358. PubMed ID: 28901534
[TBL] [Abstract][Full Text] [Related]
5. Isotretinoin and candida immunotherapy for recalcitrant warts in solid organ transplant recipients.
Herold M; Nielson C; Longo MI
Dermatol Ther; 2019 Mar; 32(2):e12803. PubMed ID: 30536495
[TBL] [Abstract][Full Text] [Related]
6. Cryotherapy plus low-dose oral isotretinoin vs cryotherapy only for the treatment of anogenital warts: a randomized clinical trial.
Reyna-Rodríguez IL; Chavez-Alvarez S; Garza-Rodríguez V; Franco-Marquez R; Gonzalez-Martinez G; Ocampo-Candiani J; Villarreal-Martinez A
Arch Dermatol Res; 2021 Dec; 313(10):815-827. PubMed ID: 33433720
[TBL] [Abstract][Full Text] [Related]
7. Complete remission of recalcitrant viral warts under oral isotretinoin in a patient with low-grade B-cell lymphoma.
Monastirli A; Matsouka P; Pasmatzi E; Melachrinou M; Georgiou S; Solomou E; Zoumbos N; Tsambaos D
Acta Derm Venereol; 2005; 85(4):358-60. PubMed ID: 16191865
[No Abstract] [Full Text] [Related]
8. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin.
Rademaker M
Australas J Dermatol; 2010 Nov; 51(4):248-53. PubMed ID: 21198520
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of using a combination of intralesional purified protein derivative with low dose isotretinoin in the treatment of recalcitrant common warts.
Diab N; Atef H; Salah E
Dermatol Ther; 2022 Jun; 35(6):e15457. PubMed ID: 35297138
[TBL] [Abstract][Full Text] [Related]
10. Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions.
Chu S; Michelle L; Ekelem C; Sung CT; Rojek N; Mesinkovska NA
Arch Dermatol Res; 2021 Aug; 313(6):391-430. PubMed ID: 33151346
[TBL] [Abstract][Full Text] [Related]
11. High versus low dose oral isotretinoin in the treatment of cutaneous and genital warts.
Nofal A; Fawzy MM; Eldeeb F; Nofal H; El-Hawary EE
Dermatol Ther; 2022 Dec; 35(12):e15964. PubMed ID: 36346210
[TBL] [Abstract][Full Text] [Related]
12. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
[TBL] [Abstract][Full Text] [Related]
13. Complete remission of recalcitrant genital warts with a combination approach of surgical debulking and oral isotretinoin in a patient with systemic lupus erythematosus.
Yew YW; Pan JY
Dermatol Ther; 2014; 27(2):79-82. PubMed ID: 24703263
[TBL] [Abstract][Full Text] [Related]
14. A novel therapeutic approach to plane warts: a report on two cases.
Miljkovic J
Acta Dermatovenerol Alp Pannonica Adriat; 2012 Sep; 21(3):63-4. PubMed ID: 23267875
[TBL] [Abstract][Full Text] [Related]
15. Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne.
DiGiovanna JJ; Langman CB; Tschen EH; Jones T; Menter A; Lowe NJ; Eichenfield L; Hebert AA; Pariser D; Savin RP; Smith SR; Jarratt M; Rodriguez D; Chalker DK; Kempers S; Ling M; Rafal ES; Sullivan S; Kang S; Shah LP; Wu E; Newhouse J; Pak J; Eberhardt DR; Bryce GF; McLane JA; Ondovik M; Chin C; Khoo KC; Rich P
J Am Acad Dermatol; 2004 Nov; 51(5):709-17. PubMed ID: 15523348
[TBL] [Abstract][Full Text] [Related]
16. Dermatological indications for the use of isotretinoin beyond acne.
Forbat E; Ali FR; Al-Niaimi F
J Dermatolog Treat; 2018 Nov; 29(7):698-705. PubMed ID: 29480033
[TBL] [Abstract][Full Text] [Related]
17. Oral isotretinoin for acne, adjusting treatment according to patient's response.
Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
[TBL] [Abstract][Full Text] [Related]
18. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
[TBL] [Abstract][Full Text] [Related]
19. Low-dose oral isotretinoin for the treatment of warts: A controversial issue.
Nofal A; Fawzy MM
Dermatol Ther; 2020 Nov; 33(6):e13673. PubMed ID: 32449195
[No Abstract] [Full Text] [Related]
20. On isotretinoin dosing, adverse effects, and efficacy.
Berk DR
Australas J Dermatol; 2011 May; 52(2):147-8; author reply 148. PubMed ID: 21605103
[No Abstract] [Full Text] [Related]
[Next] [New Search]
